Bronwen Bastone - Jun 15, 2023 Form 4 Insider Report for Enfusion, Inc. (ENFN)

Role: Chief People Officer
Signature: /s/ Matthew Campobasso, as Attorney-in-Fact
Stock symbol: ENFN
Transactions as of: Jun 15, 2023
Transactions value $: -$95,885
Form type: 4
Date filed: 6/20/2023, 04:20 PM
Previous filing: May 26, 2023
Next filing: Aug 10, 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ENFN	Class A Common Stock	Award	$0	+1.29K	+0.77%	$0.00	167K	Jun 15, 2023	Direct	F1
transaction	ENFN	Class A Common Stock	Tax liability	-$3.85K	-434	-0.26%	$8.87	167K	Jun 15, 2023	Direct	F2
transaction	ENFN	Class A Common Stock	Tax liability	-$92K	-10.4K	-6.22%	$8.87	157K	Jun 15, 2023	Direct	F3

Showing 1 to 3 of 3 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Consists of fully vested shares issued under the Enfusion, Inc. 2021 Stock Option and Incentive Plan in connection with the previously disclosed pre-IPO termination of the Enfusion Ltd. LLC Change in Control Bonus Plan (the "Shares").
F2	Consists of shares withheld to satisfy tax withholding obligations resulting from delivery of the Shares to the reporting person.
F3	Consists of shares withheld by the issuer to satisfy tax withholding obligations upon vesting of restricted stock units; not an open market transaction.